Impact of medical treatment on storage vs voiding symptoms and nocturia frequency

Prof. Roehrborn talks about a new predictive analytics solution that projects LUTS changes in individual profiles with PBO, DUT, TAM or CT therapy, using baseline characteristics that define the patient risk of disease progression.